Menu

Laparoscopic radical prostatectomy: oncological evaluation after 1,000 cases at Montsouris Institute - Guillonneau B, el-Fettouh H, Baumert H, Cathelineau X, Doublet JD, Fromont G, Vallancien G, Department of Urology, Institut Mutualiste Montsouris, Paris, France. J Urol 2003;169:1261-1266

By Smith J.A. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite

Multivariate models to predict clinically important outcomes at prostatectomy for patients with organ-confined disease and needle biopsy Gleason scores of 6 or less

By DiMarco D.S., Blute M.L., Zincke H., Cheville J.C., Riehle D.L., Lohse C.M., Pankratz V.S., Sebo T.J. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite

Trends in prostate cancer mortality among black men and white men in the United States - Chu KC, Tarone RE, Freeman HP, Center to Reduce Cancer Health Disparities, National Cancer Institute, Bethesda, MD. Cancer 2003;97:1507-1516

By Carroll P.R. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite

Current issues in the management of advanced squamous cell carcinoma of the penis

By Syed S., Eng T.Y., Thomas C.R., Thompson I.M., Weiss G.R. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite

Informed consent for cancer screening with prostate-specific antigen: how well are men getting the message? - Chan EC, Vernon SW, O'Donnell FT, Ahn C, Greisinger A, Aga DW, Division of General Internal Medicine, University of Texas-Houston Medical School, Houston, TX. Am J Public Health 2003;93:779-785

By Carroll P.R. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite

Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer - Rhodes DR, Sanda MG, Otte AP, Chinnaiyan AM, Rubin MA, Department of Pathology, University of Michigan School of Medicine, Ann Arbor, MI. J Natl Cancer Inst 2003;95:661-668

By Chatta G. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite

Bone histology at autopsy and matched bone scintigraphy findings in patients with hormone refractory prostate cancer: the effect of bisphosphonate therapy on bone scintigraphy results - Roudier MP, Vesselle H, True LD, Higano CS, Ott SM, King SH, Vessella RL, Department of Urology, University of Washington, Seattle, WA. Clin Exp Metastasis 2003;20:171-180

By Smith J.A. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite

Renal cell carcinoma (RCC) and telomerase activity: relationship to stage

By Mekhail T.M., Kawanishi-Tabata R., Tubbs R., Novick A., Elson P., Ganapathi R., Ganapathi M., Bukowski R. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite

Chemotherapy and cystectomy for invasive transitional cell carcinoma of bladder

By Raghavan D. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite

Critical review of complementary therapies for prostate cancer - Wilkinson S, Chodak GW, Midwest Prostate and Urology Health Center, Weiss Memorial Hospital, Chicago, IL. J Clin Oncol 2003;21:2199-2210

By Chatta G. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite